Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism-Reference-Cited by-同舟云学术

Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism

Published:2016-09-19 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

González-Mariscal Isabel,Krzysik-Walker Susan M.,Doyle Máire E.,Liu Qing-Rong,Cimbro Raffaello,Santa-Cruz Calvo Sara,Ghosh Soumita,Cieśla Łukasz,Moaddel Ruin,Carlson Olga D.,Witek Rafal P.,O’Connell Jennifer F.,Egan Josephine M.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep33302.pdf

Reference46 articles.

1. Silvestri, C. & Di Marzo, V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab 17, 475–490 (2013).

2. Matias, I. et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J. Clin. Endocrinol. Metab. 91, 3171–3180 (2006).

3. Sarzani, R. et al. Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients. Metabolism . 58, 361–367 (2009).

4. Ravinet Trillou, C. et al. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 284, R345–R353 (2003).

5. Despres, J. P., Golay, A. & Sjostrom, L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353, 2121–2134 (2005).

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the evolutionary trajectory and functional landscape of cannabinoid receptors: A comprehensive bioinformatic analysis;Computational Biology and Chemistry;2024-10

2. Effects of in utero delta-9-tetrahydrocannabinol (THC) exposure on fetal and infant musculoskeletal development in a preclinical nonhuman primate model;PLOS ONE;2024-07-31

3. Efficacy in diet‐induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837;British Journal of Pharmacology;2024-06-17

4. Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans;Diabetologia;2024-06-12

5. Deorphanization of G Protein Coupled Receptors: A Historical Perspective;MOL PHARMACOL;2024